Tamsulosin

About Haorui Products Technology Contact

Tamsulosin API

 

Haorui supplies high quality Tamsulosin API produced by our GMP facility that has been successfully inspected by the FDA. We offer competitive prices and support our products with reliable technical and regulatory services. Tamsulosin API is available from R&D to commercial quantities. Please contact us for more details.

The following information is provided for general information purposes ONLY.

 

What is Tamsulosin?

Tamsulosin (rINN) ( /tæmˈsuːlɵsɨn/ or /tæmsʉˈloʊsɨn/) is an ¦Á1a-selective alpha blocker used in the symptomatic treatment of benign prostatic hyperplasia (BPH). Tamsulosin was developed by Yamanouchi Pharmaceuticals (now part of Astellas Pharma) and was first marketed in 1996 under the trade name Flomax. It is now marketed by various companies under licence, including Boehringer-Ingelheim and CSL.

Tamsulosin hydrochloride extended-release capsules are marketed under the trade names Flomax, Flomaxtra, Contiflo XL and Urimax, although generic, non-modified-release capsules are still approved and marketed in many countries (such as Canada). In Mexico it is marketed as Secotex and as Harnal D in Japan and Indonesia. In Egypt, Italy and Iceland, it is marketed under the trade name Omnic by Astellas Pharma Europe.

Mechanism

Main article: Alpha blocker

Tamsulosin is a selective ¦Á1 receptor antagonist that has preferential selectivity for the ¦Á1A receptor in the prostate versus the ¦Á1B receptor in the blood vessels.

Clinical uses

Tamsulosin is primarily used for benign prostatic hyperplasia, but is sometimes used for the passage of kidney stones by the same mechanism of smooth muscle relaxation via alpha antagonism.

Adverse effects

Two ADRs (Adverse Drug Reactions) have been reported:

Immunologic: It contains a sulfa moiety, thus causing typical reactions to sulfa drugs.

Ophthalmologic: Patients taking tamsulosin are prone to a complication known as floppy iris syndrome during cataract surgery. Adverse outcomes of the surgery are greatly reduced by the surgeon's prior knowledge of the patient's history with this drug, and thus having the option of alternative techniques.

Tamsulosin has also affected the sexual function in men. Tamsulosin can cause males to experience retrograde ejaculation. In males, retrograde ejaculation occurs when the fluid to be ejaculated, which would normally exit the body via the urethra, is redirected to the urinary bladder. Normally, the sphincter of the bladder contracts and the ejaculate goes to the urethra, the area of least pressure. In retrograde ejaculation, this sphincter does not function properly.

Occasionally, tamsulosin can cause a drop in blood pressure, rarely resulting in dizziness or fainting. Other reported side effects include headache, dizziness, nasal congestion, and palpitations.

Clinical comparison

Although prostate specific, it does not have the prostate apoptotic effects of other alpha-blockers such as doxazosin and terazosin.

Use in combination therapy

The results of the CombAT (Combination of Avodart and Tamsulosin) trial in 2008 demonstrated that treatment with the combination of dutasteride (Avodart) and tamsulosin provides greater symptom benefits compared to monotherapy with either agent alone for treatment of benign prostatic hyperplasia.

¡¡

Chemical Structure

Molecular Formula C20H28N2O5S

Disclaimer:

Information on this page is provided for general information purposes. You should not make a clinical treatment decision based on information contained in this page without consulting other references including the package insert of the drug, textbooks and where relevant, expert opinion. We cannot be held responsible for any errors you make in administering drugs mentioned on this page, nor for use of any erroneous information contained on this page.

Haorui - Your Partner to Pharmaceutical Success - Copy Right Reserved